Found 7 matching trials
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
PHASE2The overall purpose of this research study is to find a better way to treat...
Location
H. Lee Moffitt Cancer Center and Research Institute
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
PHASE2This randomized phase II trial is studying how well giving vaccine therapy ...
Location
University of Chicago Comprehensive Cancer Center
High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
PHASE2The goal of this clinical research study is to learn if high-dose interleuk...
Location
University of Texas MD Anderson Cancer Center
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
PHASE2This pilot phase II trial studies how well giving vaccine therapy works in ...
Location
University of Southern California
Vaccine Therapy in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Vaccines made from a person's white blood cells and melanoma cel...
Location
Baylor University Medical Center
MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma
PHASE2This study is being done to evaluate the safety and the clinical activity o...
Location
GSK Investigational Site
Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Vaccines made from a tumor antigen gene may make the body build ...
Location
University of Chicago Cancer Research Center